These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34747372)

  • 1. Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB).
    Gupta A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    J Immunother; 2022 Feb-Mar 01; 45(2):132-137. PubMed ID: 34747372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
    Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
    Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
    JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database.
    Gupta A; Omeogu CH; Islam JY; Joshi AR; Akinyemiju TF
    Cancer; 2022 Aug; 128(16):3099-3108. PubMed ID: 35719098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
    Zhang D; Tailor TD; Kim C; Atkins MB; Braithwaite D; Akinyemiju T
    J Immunother; 2021 Jun; 44(5):198-203. PubMed ID: 33758148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare access dimensions and uterine cancer survival: a national cancer database study.
    Anastasio MK; Gupta A; Akinyemiju TF; Previs RA
    Front Oncol; 2023; 13():1263371. PubMed ID: 37869101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.
    Klugman M; Xue X; Ginsberg M; Cheng H; Rohan T; Hosgood HD
    J Racial Ethn Health Disparities; 2020 Apr; 7(2):316-326. PubMed ID: 31713221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
    Goyal G; Kommalapati A; Bartley AC; Gunderson TM; Adjei AA; Go RS
    Lung Cancer; 2018 Aug; 122():214-219. PubMed ID: 30032834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of racial disparities in early-stage lung cancer treatment.
    Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients.
    Hardy D; Xia R; Liu CC; Cormier JN; Nurgalieva Z; Du XL
    Cancer; 2009 Oct; 115(20):4807-18. PubMed ID: 19626650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US.
    Islam JY; Braithwaite D; Zhang D; Guo Y; Tailor TD; Akinyemiju T
    Cancer Med; 2023 Apr; 12(7):8567-8580. PubMed ID: 36533434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
    Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE; Owonikoko TK; Ramalingam SS; Curran WJ; Higgins KA
    Clin Lung Cancer; 2017 Nov; 18(6):706-718. PubMed ID: 28601387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer.
    Zhou K; Shi H; Chen R; Cochuyt JJ; Hodge DO; Manochakian R; Zhao Y; Ailawadhi S; Lou Y
    JAMA Netw Open; 2021 Jan; 4(1):e2032276. PubMed ID: 33433596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer.
    Pichert MD; Canavan ME; Maduka RC; Li AX; Ermer T; Zhan PL; Kaminski M; Udelsman BV; Blasberg JD; Park HS; Goldberg SB; Boffa DJ
    JAMA Netw Open; 2022 Aug; 5(8):e2224478. PubMed ID: 35925606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Immunotherapy With the Overall Survival of Inoperable Stage III Non-small Cell Lung Cancer Patients Who Do Not Receive Chemoradiation.
    Amin SA; Baine MJ; Rahman I; Lin C
    J Immunother; 2023 Jan; 46(1):14-21. PubMed ID: 36256124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.
    Potter AL; Rosenstein AL; Kiang MV; Shah SA; Gaissert HA; Chang DC; Fintelmann FJ; Yang CJ
    BMJ; 2022 Mar; 376():e069008. PubMed ID: 35354556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.